PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY
Abstract
Authors
U Fiocco F Cantini M Matucci Cerinic C Ferri C Botsios M Intorcia S Bombardieri
U Fiocco F Cantini M Matucci Cerinic C Ferri C Botsios M Intorcia S Bombardieri
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now